Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Evexia Lifecare's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524444 vs KHC, GIS: Buyback Yield % Comparison
For the Medical Distribution subindustry, Evexia Lifecare's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evexia Lifecare Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Evexia Lifecare's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Evexia Lifecare's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evexia Lifecare (BOM:524444) has a Buyback Yield % of 0.00 as of Aug. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Evexia Lifecare and its competitors. According to the industry distribution chart, Evexia Lifecare ranks #999999 out of 35 companies in the Medical Distribution industry.
Is Evexia Lifecare's Buyback Yield % too high?
Evexia Lifecare's current Buyback Yield % is 0.00. Based on the distribution chart, Evexia Lifecare ranks #999999 out of 35 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Evexia Lifecare has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Evexia Lifecare's Buyback Yield % compare to KHC and GIS?
According to the Medical Distribution industry distribution chart, Evexia Lifecare ranks #999999 out of 35 companies for Buyback Yield %. This places Evexia Lifecare in the lower half of its industry. The industry median Buyback Yield % is 0.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.10, based on 35 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Evexia Lifecare and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evexia Lifecare's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evexia Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Evexia Lifecare (BOM:524444) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1.87, compared to a current price of ₹1.40 — trading 25.1% below its estimated fair value. The current Buyback Yield % is 0.00. Evexia Lifecare's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Evexia Lifecare (BOM:524444), the current Buyback Yield % is 0.00 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evexia Lifecare (BOM:524444) Overvalued in 2026?
Based on GuruFocus' analysis, Evexia Lifecare stock appears to be undervalued.
The current stock price of ₹1.40 is trading 25.1% below its estimated GF Value™ of ₹1.87.
GuruFocus considers Evexia Lifecare to be Modestly Undervalued.
Key valuation signals for BOM:524444:
Buyback Yield %: 0.00
GF Value™: ₹1.87 vs. price of ₹1.40 (25.1% below fair value)
No single metric tells the full story. See the BOM:524444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evexia Lifecare Ltd diversified healthcare company specializing in the trading of pharmaceutical chemicals, retail pharmacy services, diagnostic solutions, and personal healthcare products, committed to improving well-being with quality and reliability.
67GF Score
Get the complete analysis for BOM:524444
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524444 has been successfully added to your 
